Search - tctmd.com

Displaying 141 - 160 of 238

Sort: Relevancy | Date

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Ultrafiltration in Practice: Best practices from a high-volume center

Presenter: Mark Hofmeyer

March 04, 2024

Presentation THT 2024

Adjusted ultrafiltration vs adjusted diuretics: AVOID-HF and REVERSE-HF

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

Ultrafiltration in acute decompensated heart failure: a reappraisal of CARRESS-HF

Presenter: Maria Rosa Costanzo

March 04, 2024

Presentation THT 2024

Advances in Hemocompatibility

Presenter: Mandeep R. Mehra

March 04, 2024

Presentation THT 2024

Right Heart Hemodynamics and TR: Predictors of Adverse Clinical Outcomes

Presenter: Karl-Philipp Rommel

March 04, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

Presentation THT 2024

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Presenter: Martin B. Leon

March 04, 2024

Presentation THT 2024

Reducing Congestion by Removing Fluid From the Interstitium

Presenter: William T. Abraham

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Presentation THT 2024

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Presenter: James Januzzi

March 04, 2024

Presentation THT 2024

Atrial Functional MR: Diagnosis and Therapy Implications

Presenter: Federico M. Asch

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

Presentation THT 2024

Contemporary Pharmacological Therapies for Acute Heart Failure

Presenter: Wilfried Mullens

March 04, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Todd Neale

March 23, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Advertisement

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Ultrafiltration in Practice: Best practices from a high-volume center

Adjusted ultrafiltration vs adjusted diuretics: AVOID-HF and REVERSE-HF

Ultrafiltration in acute decompensated heart failure: a reappraisal of CARRESS-HF

Advances in Hemocompatibility

Right Heart Hemodynamics and TR: Predictors of Adverse Clinical Outcomes

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

The TMVR Landscape: Second Generation Devices and Clinical Trial Pathways

Reducing Congestion by Removing Fluid From the Interstitium

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

BrioHealth Solutions: Pump and Clinical Trial Design

Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials

Atrial Functional MR: Diagnosis and Therapy Implications

Mechanisms of Diuretic Resistance

Contemporary Pharmacological Therapies for Acute Heart Failure

The Promise of AI for Improving Health Equity in Heart Failure

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content